IPI Journal

IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare.

[IPI Journal @ipimediaworld]

Canton of Geneva supports Connect in Pharma 2023
Geneva’s position as a leading European... https://t.co/RaFPUZT4fi
https://t.co/RaFPUZT4fi

[IPI Journal @ipimediaworld]

AstraZeneca’s Tagrisso delivers positive results
The company’s phase 3 study showed trea... https://t.co/FiXlhvh5gi
https://t.co/FiXlhvh5gi

[IPI Journal @ipimediaworld]

AeroGo
Current Edition
To access thi... https://t.co/4jT7hNPNst
https://t.co/4jT7hNPNst

[IPI Journal @ipimediaworld]

Pharmalex
Current Edition
To access thi... https://t.co/kwxqbN8W8o
https://t.co/kwxqbN8W8o

[IPI Journal @ipimediaworld]

It’s All About Stem Cells
Current Edition

It... https://t.co/AaAQxj2RQK
https://t.co/AaAQxj2RQK

[IPI Journal @ipimediaworld]

DDL 2023
The Drug Delivery to the Lungs Conferen... https://t.co/fYbrqAQqWE
https://t.co/fYbrqAQqWE

[IPI Journal @ipimediaworld]

Connect in Pharma launches partnerships for global health innovation
Sciad Newswire / Connect in Pharma anno... https://t.co/Dq2NAbi5c8
https://t.co/Dq2NAbi5c8

[IPI Journal @ipimediaworld]

ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead
The European Laboratory Research & ... https://t.co/krJhyQLo4w
https://t.co/krJhyQLo4w

[IPI Journal @ipimediaworld]

First patient dosed in pivotal CureVac flu vaccine study
Modified influenza vaccine candidates h... https://t.co/IxqLOaKUgm
https://t.co/IxqLOaKUgm

[IPI Journal @ipimediaworld]

Positive opinion for Gilead’s Hepcludex
The vital recommendation ensures market... https://t.co/KaWtkdz4eA
https://t.co/KaWtkdz4eA

[IPI Journal @ipimediaworld]

Endogena finalises enrolment for retinitis pigmentosa trial
The treatment is a small molecule that ... https://t.co/pyFuGjH2JD
https://t.co/pyFuGjH2JD

[IPI Journal @ipimediaworld]

Ginkgo Bioworks, Boehringer Ingelheim partner on breakthrough therapies
Ginkgo Bioworks, a Boston-based biotech... https://t.co/HevFYUdjct
https://t.co/HevFYUdjct

[IPI Journal @ipimediaworld]

Novavax to reduce workforce by 25%
Maryland-based vaccine maker Novavax an... https://t.co/iuUdzO8HMj
https://t.co/iuUdzO8HMj

[IPI Journal @ipimediaworld]

Roche bets on Zion HER2 brain metastases prospect
Roche has acquired the global rights to... https://t.co/gJinCgfCvX
https://t.co/gJinCgfCvX

[IPI Journal @ipimediaworld]

Explore The Latest Trends At PHARMAP 2023
Digital transformation, AI, Big Data an... https://t.co/bWOXJpILx2
https://t.co/bWOXJpILx2

[IPI Journal @ipimediaworld]

VYNE and Tay Therapeutics reach licence agreement
The deal involves an oral BET inhibitor... https://t.co/f9qJs4t4hc
https://t.co/f9qJs4t4hc

[IPI Journal @ipimediaworld]

SporeGen and Destiny advance research collaboration
The duo has partnered on developing a b... https://t.co/TLBJBZyvRs
https://t.co/TLBJBZyvRs

[IPI Journal @ipimediaworld]

NICE approves expanded use of Yescarta and Tecartus
Kite’s two CAR T-Cell therapies involve... https://t.co/nOytvMYA1t
https://t.co/nOytvMYA1t

[IPI Journal @ipimediaworld]

Positive CHMP opinion for UCB’s bimekizumab
Therapy concerns the treatment of adult... https://t.co/IZjWomCaYk
https://t.co/IZjWomCaYk

[IPI Journal @ipimediaworld]

King's College London and Grünenthal join forces to ease pain
Duo will collaborate to develop pluripo... https://t.co/AQRAvJ5mV4
https://t.co/AQRAvJ5mV4